Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Critical Reviews in Biochemistry and Molecular Biology is Scopus-indexed (Q1, CiteScore 13.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1040-9238Verify ISSN ↗1549-7798Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 35 / 448 | 92nd | Q1 |
| Molecular Biology | 39 / 414 | 90th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1972–present, best quartile Q1, CiteScore 13.7.
Critical Reviews in Biochemistry and Molecular Biology is Q1 in Biochemistry (rank 35 of 448) and Q1 in Molecular Biology (rank 39 of 414), by CiteScore 2025.
Critical Reviews in Biochemistry and Molecular Biology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.7, which places it in quartile Q1 at the 92nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.553, quartile Q1, with an H-index of 136.
Critical Reviews in Biochemistry and Molecular Biology is published by Taylor and Francis Ltd. Its print ISSN is 1040-9238 and its online ISSN is 1549-7798.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Critical Reviews in Biochemistry and Molecular Biology has an h-index of 190 and a 2-year mean of 8.97 citations per paper (OpenAlex). Its Scopus CiteScore is 13.7, quartile Q1. On 2-year citations it ranks #21 of 442 Scopus journals in Biochemistry.
Critical Reviews in Biochemistry and Molecular Biology published 13 papers in 2025; its busiest recent year was 2021 with 41. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2021–2026), authors are most often from United States (46%), China (9.7%) and United Kingdom (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.